Research output: Contribution to journal › Article › peer-review
Heather J Bax, Jitesh Chauhan, Chara Stavraka, Atousa Khiabany, Mano Nakamura, Giulia Pellizzari, Kristina M Ilieva, Sara Lombardi, Hannah J Gould, Christopher J Corrigan, Stephen J Till, Sidath Katugampola, Paul S Jones, Claire Barton, Anna Winship, Sharmistha Ghosh, Ana Montes, Debra H Josephs, James F Spicer, Sophia N Karagiannis
Original language | English |
---|---|
Article number | E1631 |
Pages (from-to) | 1-21 |
Number of pages | 21 |
Journal | Cells |
Volume | 9 |
Issue number | 7 |
Early online date | 7 Jul 2020 |
DOIs | |
Accepted/In press | 3 Jun 2020 |
E-pub ahead of print | 7 Jul 2020 |
Published | 7 Jul 2020 |
Bax_et_al_cells_854703_030720.pdf, 1.79 MB, application/pdf
Uploaded date:03 Jul 2020
Version:Accepted author manuscript
Licence:CC BY
Bax_et_al_Cells_09_01631.pdf, 5.38 MB, application/pdf
Uploaded date:30 Jul 2020
Version:Final published version
Licence:CC BY
Basophils are involved in manifestations of hypersensitivity, however, the current understanding of their propensity for activation and their prognostic value in cancer patients remains unclear. As in healthy and atopic individuals, basophil populations were identified in blood from ovarian cancer patients (n = 53) with diverse tumor histologies and treatment histories. Ex vivo basophil activation was measured by CD63 expression using the basophil activation test (BAT). Irrespective of prior treatment, basophils could be activated by stimulation with IgE- (anti-FcεRI and anti-IgE) and non-IgE (fMLP) mediated triggers. Basophil activation was detected by ex vivo exposure to paclitaxel, but not to other anti-cancer therapies, in agreement with a clinical history of systemic hypersensitivity reactions to paclitaxel. Protein and gene expression analyses support the presence of basophils (CCR3, CD123, FcεRI) and activated basophils (CD63, CD203c, tryptase) in ovarian tumors. Greater numbers of circulating basophils, cells with greater capacity for ex vivo stimulation (n = 35), and gene signatures indicating the presence of activated basophils in tumors (n = 439) were each associated with improved survival in ovarian cancer. Circulating basophils in cancer patients respond to IgE- and non-IgE-mediated signals and could help identify hypersensitivity to therapeutic agents. Activated circulating and tumor-infiltrating basophils may be potential biomarkers in oncology.
King's College London - Homepage
© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454